Updated · 8 episodes · 1 show · 8 source notes

concept

Creatine Monohydrate Evidence

Definition

Creatine monohydrate evidence is the episode’s frame that creatine monohydrate is an unusually well-tested sports supplement for healthy people, with practical dosing and tolerance mattering more than expensive forms or fast saturation.

Current Synthesis

The Norton source treats creatine as a rare supplement where evidence is comparatively strong. Creatine monohydrate is presented as safe and effective for healthy people, with benefits around phosphocreatine stores, exercise performance, recovery, lean mass, strength, and possible cognition. Other forms are framed as unlikely to justify extra cost relative to monohydrate.

The dosing stance is pragmatic. Loading saturates stores faster, usually within about a week, but five grams per day without loading reaches the same endpoint more slowly. If creatine causes gastrointestinal irritation, Norton favors avoiding loading and splitting doses. The concept therefore belongs next to Context-Dependent Biomedical Interventions and Supplement Label Accuracy while still being more positive than the wiki’s weaker-evidence supplement examples.

The Huberman Essentials source independently reinforces the performance and hydration branch, describing creatine as repeatedly supported in controlled studies and using about five grams daily for a roughly 180-pound person as its example. Its claim of a 12% to 20% power-output increase across 66 studies is retained as source-scoped because the episode note does not identify the review, populations, training status, outcomes, or formulation.

The fitness-tools episode agrees that monohydrate is the effective low-cost form and that loading is unnecessary, but proposes weight-scaled daily doses of roughly 10-15 grams for people around 185-250 pounds and three to five grams for lighter people. Because that higher range is not reconciled with the existing five-gram examples or supported by study details in the summary, it remains a contested source-specific dosing claim rather than a new default.

The Galpin interview returns to a more conservative three-to-five-gram daily example and clarifies that creatine works through repeated intake over weeks rather than as a once-weekly or immediate pre-workout aid. It broadens possible benefits to recovery, bone mineral density, and cognition while explicitly denying that creatine prevents or treats neurodegenerative disease, traumatic brain injury, or concussion. These additions strengthen the consistency principle without resolving the dose disagreement or turning exploratory outcomes into treatment claims.

The earlier headache episode reports a small human pilot using 0.4 grams per kilogram per day for six months after traumatic brain injury and describes a large difference in headache frequency. That is a materially different population, dose, and outcome from the sports-supplement evidence, and it directly tensions the later Galpin boundary. Without study methods, sample size, replication, adverse-event detail, or a current clinical synthesis in the supplied note, the pilot remains a contested research signal rather than support for treating TBI or post-traumatic headache with creatine.

The full strength episode independently returns to five grams daily as a standard sports-supplement example and says timing is not important. This strengthens the conservative consistency-based default while leaving the higher weight-scaled fitness-tools range and the clinical TBI pilot unresolved.

The 2021 muscle episode is the underlying full-length source for the later Essentials edit. It describes creatine as supporting high-intensity activity, power, fatigue resistance, and possible cognition, but does not add independent replication or resolve the existing dosing and clinical-use disagreements.

Patrick adds a brain-stress rationale while also widening the dose disagreement. She describes muscle as competing strongly for supplemental creatine, cites small studies using about ten grams or much higher weight-scaled doses under sleep deprivation or cognitive impairment, and reports taking ten grams daily with temporary increases during travel or sleep loss. These observations keep creatine’s performance evidence separate from preliminary cognitive, injury, and disease contexts; they do not establish a routine brain-targeting dose or treatment protocol.

Key Claims

  • Creatine monohydrate is treated as the most tested, safe, effective, and cost-justified form compared with more expensive alternatives.
  • The source links creatine to phosphocreatine stores, exercise performance, recovery, lean mass, strength, and possible cognition.
  • Kidney and liver concerns are treated as debunked for healthy people, while the hair-loss concern rests mainly on one unreplicated DHT study.
  • Loading saturates stores faster, but about five grams per day without loading can reach the same endpoint over time, and precise daily timing is not treated as important.
  • Gastrointestinal tolerance and adherence can justify skipping loading or splitting doses.
  • A third source agrees on formulation and optional loading but gives a substantially higher dose for heavier people, creating an unresolved dosing qualification.
  • A later source rejects brain-injury treatment claims, while high-dose pilots or practices for post-traumatic headache, brain stress, and cognitive impairment remain population-specific, unresolved, and unable to displace conservative sports examples or support self-treatment.

Evidence

Counterevidence & Qualifications

This concept is not individualized supplement advice. Kidney disease, liver disease, pregnancy, adolescence, medication interactions, competitive-sport rules, product contamination, gastrointestinal intolerance, diet pattern, and clinical conditions can change the risk calculation. “Healthy people” is part of the source’s safety boundary, not a universal claim. The 66-study count and 12% to 20% power figure cannot be independently evaluated from the episode summary; the 10-15 gram range, Patrick’s ten-gram routine, and temporary 20-25-gram practice should not be generalized without evidence or clinical context. Possible cognitive or bone effects do not establish prevention or treatment of neurological disease or injury. The post-traumatic pilot used a much higher weight-scaled dose and cannot override the later explicit non-treatment boundary without fuller evidence and clinical guidance. The 2021 full episode and its Essentials edit are editorially related, not independent confirmation.

What Changed

  • Added preliminary brain-stress and cognitive-impairment contexts without converting them into treatment claims.
  • Expanded the unresolved dosing range while preserving conservative sports examples separately from higher-dose research and personal practice.

Sources

8 source notes across 1 show
  1. Essentials: The Science of Eating for Health, Fat Loss & Lean Muscle | Dr. Layne Norton Huberman Lab
  2. Essentials: Build Muscle Size, Increase Strength & Improve Recovery Huberman Lab
  3. Science-Supported Tools to Accelerate Your Fitness Goals Huberman Lab
  4. GUEST SERIES | Dr. Andy Galpin: Optimal Nutrition & Supplementation for Fitness Huberman Lab
  5. How to Stop Headaches Using Science-Based Approaches Huberman Lab
  6. GUEST SERIES | Dr. Andy Galpin: Optimal Protocols to Build Strength & Grow Muscles Huberman Lab
  7. Science of Muscle Growth, Increasing Strength & Muscular Recovery Huberman Lab
  8. The Best Vitality & Health Protocols | Dr. Rhonda Patrick Huberman Lab